Catherine Jacob-Dolan

7.7k total citations · 1 hit paper
16 papers, 532 citations indexed

About

Catherine Jacob-Dolan is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Catherine Jacob-Dolan has authored 16 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Catherine Jacob-Dolan's work include SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (7 papers) and vaccines and immunoinformatics approaches (3 papers). Catherine Jacob-Dolan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (7 papers) and vaccines and immunoinformatics approaches (3 papers). Catherine Jacob-Dolan collaborates with scholars based in United States, Netherlands and Germany. Catherine Jacob-Dolan's co-authors include Dan H. Barouch, Jingyou Yu, Katherine McMahan, Ai‐ris Y. Collier, Jinyan Liu, Daniel Sellers, Abishek Chandrashekar, Michelle A. Lifton, Cindy Wu and Julia Barrett and has published in prestigious journals such as Nature, JAMA and Journal of Virology.

In The Last Decade

Catherine Jacob-Dolan

15 papers receiving 520 citations

Hit Papers

Vaccines elicit highly conserved cellular immunity to SAR... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Jacob-Dolan United States 10 434 121 116 68 53 16 532
Deleah Pettie United States 5 562 1.3× 134 1.1× 78 0.7× 82 1.2× 52 1.0× 5 654
Melanie H. Dietrich Australia 10 304 0.7× 93 0.8× 117 1.0× 33 0.5× 45 0.8× 15 446
Abishek Chandrashekar United States 8 365 0.8× 77 0.6× 138 1.2× 32 0.5× 51 1.0× 14 454
Inesa Hyseni Italy 6 488 1.1× 124 1.0× 58 0.5× 66 1.0× 33 0.6× 6 554
Linda Benincasa Italy 8 448 1.0× 134 1.1× 59 0.5× 74 1.1× 36 0.7× 14 496
Alexander S. Hahn Germany 8 619 1.4× 181 1.5× 100 0.9× 91 1.3× 106 2.0× 18 762
Charles Kevin Tiu Singapore 3 765 1.8× 108 0.9× 76 0.7× 131 1.9× 42 0.8× 4 811
Rhys Pryce United Kingdom 8 514 1.2× 134 1.1× 88 0.8× 44 0.6× 147 2.8× 11 695
Rosa Isela Gálvez United States 5 311 0.7× 95 0.8× 133 1.1× 40 0.6× 45 0.8× 13 409
Ann-Kathrin Wallisch Germany 4 671 1.5× 175 1.4× 103 0.9× 91 1.3× 32 0.6× 4 713

Countries citing papers authored by Catherine Jacob-Dolan

Since Specialization
Citations

This map shows the geographic impact of Catherine Jacob-Dolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Jacob-Dolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Jacob-Dolan more than expected).

Fields of papers citing papers by Catherine Jacob-Dolan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Jacob-Dolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Jacob-Dolan. The network helps show where Catherine Jacob-Dolan may publish in the future.

Co-authorship network of co-authors of Catherine Jacob-Dolan

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Jacob-Dolan. A scholar is included among the top collaborators of Catherine Jacob-Dolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Jacob-Dolan. Catherine Jacob-Dolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wang, Liping, Chi Ngai Chan, David Hope, et al.. (2025). Mucosal boosting increases protective efficacy of an influenza vaccine in mice. iScience. 28(6). 112721–112721.
2.
Jacob-Dolan, Catherine, Michelle A. Lifton, Olivia Powers, et al.. (2024). B cell somatic hypermutation following COVID-19 vaccination with Ad26.COV2.S. iScience. 27(5). 109716–109716. 2 indexed citations
3.
Collier, Ai‐ris Y., Katherine McMahan, Catherine Jacob-Dolan, et al.. (2024). Decline of Mpox Antibody Responses After Modified Vaccinia Ankara–Bavarian Nordic Vaccination. JAMA. 332(19). 1669–1669. 12 indexed citations
4.
Nkolola, Joseph P., Jinyan Liu, Ai‐ris Y. Collier, et al.. (2024). High Frequency of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Sensitive Nucleocapsid Assays. The Journal of Infectious Diseases. 230(3). e601–e604. 3 indexed citations
5.
Lasrado, Ninaad, Marjorie Rowe, Katherine McMahan, et al.. (2024). SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity. Science Translational Medicine. 16(770). eadp8920–eadp8920. 16 indexed citations
6.
Collier, Ai‐ris Y., Catherine Brown, Katherine McMahan, et al.. (2022). Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variant. Science Translational Medicine. 14(641). eabn6150–eabn6150. 43 indexed citations
7.
Mahrokhian, Shant H., Lisa H. Tostanoski, Catherine Jacob-Dolan, et al.. (2022). Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice. npj Vaccines. 7(1). 23–23. 6 indexed citations
8.
Liu, Jinyan, Abishek Chandrashekar, Daniel Sellers, et al.. (2022). Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron. Nature. 603(7901). 493–496. 270 indexed citations breakdown →
9.
Nkolola, Joseph P., Jingyou Yu, Huahua Wan, et al.. (2022). A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaques. Science Translational Medicine. 14(665). eabo6160–eabo6160. 4 indexed citations
10.
Jacob-Dolan, Catherine, Jared Feldman, Katherine McMahan, et al.. (2021). Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques following SARS-CoV-2 Vaccination and Infection. Journal of Virology. 95(11). 12 indexed citations
11.
Yu, Jingyou, Zhenfeng Li, Xuan He, et al.. (2021). Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays. Journal of Virology. 95(11). 51 indexed citations
12.
Vidal, Samuel J., Ai‐ris Y. Collier, Jingyou Yu, et al.. (2021). Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera. Journal of Virology. 95(14). e0040421–e0040421. 24 indexed citations
13.
Yu, Jingyou, Zhenfeng Li, Xuan He, et al.. (2021). Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays. UNC Libraries. 2 indexed citations
14.
Jacob-Dolan, Catherine & Dan H. Barouch. (2021). COVID-19 Vaccines: Adenoviral Vectors. Annual Review of Medicine. 73(1). 41–54. 51 indexed citations
15.
Larocca, Rafael A., Érica Araújo Mendes, Peter Abbink, et al.. (2019). Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection against Zika Virus Challenge in Pregnant IFN-αβR−/− Mice. Cell Host & Microbe. 26(5). 591–600.e4. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026